​​This approach will require cross-functional teams to establish clear measurable outcome metrics that align technology with therapeutic goals and couple robust data generation strategies with holistic patient experience and treatment efficacy.

​In this whitepaper BMS, GSK, Merck, Novartis, UCB, Takeda, Novo Nordisk, Ypsomed and HealthXL outline the building blocks for successful selfcare programs. Here digital solutions are becoming key, rapidly evolving from an innovative approach to an expected standard of care for patients managing chronic conditions.